Phase II study of oral antineoplastons A10 [antineoplaston-A10] and AS2-1 [antineoplaston-AS2-1] in women with advanced breast cancer
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Antineoplaston-A10 (Primary) ; Antineoplaston-AS2-1 (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 12 Dec 2006 Status change
- 16 Aug 2005 New trial record.